Prevention of Cognitive Decline in ApoE4 Carriers With Subjective Cognitive Decline After EGCG and a Multimodal Intervention

NACompletedINTERVENTIONAL
Enrollment

129

Participants

Timeline

Start Date

October 30, 2019

Primary Completion Date

March 29, 2023

Study Completion Date

June 28, 2023

Conditions
Alzheimer DiseaseCognitive Decline
Interventions
DIETARY_SUPPLEMENT

EGCG

"FontUp capsules (100 mg of EGCG each)~12 months, three to five capsules per day (participant's weight ≤ 50kg: 3 capsules/day; weight \>50kg: 5 capsules/day."

DIETARY_SUPPLEMENT

Placebo EGCG

"Placebo FontUp (same appearance as active).~12 months, three to five capsules per day (participant's weight ≤ 50kg: 3 capsules/day; weight \>50kg: 5 capsules/day."

OTHER

Healthy lifestyle recommendations

Personalized advice on diet, physical activity, cognitive training, and social stimulation activities.

OTHER

Multimodal lifestyle intervention

"* Dietary intervention: personalized dietary recommendations based on MedDiet, 9 individual counseling sessions.~* Physical activity intervention: Guided gymnasium (aerobic, strength, and balance activities). Minimum one class/week the first 6months, and two classes/week from month 7 to 12). Achieve a physically active lifestyle (10,000 steps/day; individuals living with disability 8,500 steps/day). Achieve moderate physical exercise in older adults (150 to 210 minutes/week or 90 to 150 minutes depending on medical history.~* Cognitive training: NeuronUP, 3/week, 30 min sessions~* Psychoeducation: ten 90-minute sessions~* Social stimulation activities: ten to twelve 90-to-120-minute sessions."

Trial Locations (2)

08005

Barcelonabeta Brain Research Center, Barcelona

08003

Hospital del Mar Research Institute Barcelona, Barcelona

Sponsors
All Listed Sponsors
collaborator

Hospital del Mar Research Institute

UNKNOWN

collaborator

Barcelonabeta Brain Research Center, Pasqual Maragall Foundation

OTHER

lead

Parc de Salut Mar

OTHER